Mobic

In the US, Mobic (meloxicam systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Fibromyalgia, Inflammatory Conditions, Juvenile Rheumatoid Arthritis, Osteoarthritis, Rheumatoid Arthritis and Tendonitis.

US matches:

• Mobic


• Mobic Suspension

UK matches:

• Mobic Suppositories 15mg
• Mobic Suppositories 7.5mg
• Mobic Tablets 15mg
• Mobic Tablets 7.5mg
• Mobic 15mg Suppositories (SPC)
• Mobic 15mg Tablets (SPC)
• Mobic 7.5mg Suppositories (SPC)
• Mobic 7.5mg Tablets (SPC)

Ingredient matches for Mobic

Meloxicam

Meloxicam is reported as an ingredient of Mobic in the following countries:

• Argentina


• Australia


• Bahrain


• Belgium


• Colombia


• Cyprus


• Egypt


• Finland


• France


• Guyana


• Hong Kong


• Iraq


• Ireland


• Italy


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Libya


• Luxembourg


• Malaysia


• Malta


• New Zealand


• Norway


• Oman


• Peru


• Qatar


• Saudi Arabia


• Singapore


• South Africa


• Sudan


• Taiwan


• Thailand


• Tunisia


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Vietnam


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.